BioSpace News Archive

Washington-based health systems, CHI Franciscan and Virginia Mason, along with CommonSpirit Health, the parent company of CHI Franciscan, announced today they have signed a Memorandum of Understanding (MOU) to explore combining the two health systems through a formation of a Joint Operating Company.

The CureScience™ Institute, a non-profit organization, focused on the acceleration of curative therapies for unmet needs, announced today a strategic expansion of its vision and mission.

WATERTOWN, Mass., July 16, 2020 (GLOBE NEWSWIRE) -- Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage biotechnology company developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune disease, today announced the pricing of its initial public offering of 7,500,000 shares of its common stock at a public offering price of $18.00 per share, for gross proceeds of $135.0 million, before deducting underwriting discounts and commissions and offeri

Sandra S. Garrett, Ph.D. CEO of MediMergent, LLC of Rockville, MD, was recently named to the National Small Business Association (NSBA) Leadership Council

Fitwel®, the healthy building certification system operated by The Center for Active Design (CfAD), today announced the launch of its Viral Response module, which provides annual, third-party building certification of policies and practices informed by the latest public health research on mitigating the spread of infectious diseases.

Signify Health, a leading provider of technology-enabled healthcare solutions designed to keep people healthy and happy at home, announced today two executive appointments to its Episodes of Care (EOC) Division.

The International Association for the Study of Pain has revised the definition of pain for the first time since 1979, the result of a years-long process that the association hopes will lead to new ways of assessing pain.

The Oncology Institute of Hope and Innovation (TOI), the largest community oncology practice on the West Coast, announced today that it has agreed to care for an additional 180,000 patients through new contracts, strategic partnerships, and practice acquisitions.

TRIA, a principal-led architecture firm with a focus on designing unique workspaces for science, technology, and corporate clients, announced today that it is designing a new cell and genetic therapies research site in the Boston area for Vertex Pharmaceuticals, Inc. (Nasdaq: VRTX)

Arctoris Ltd. supports global research efforts to find new therapeutics against COVID-19.